243 related articles for article (PubMed ID: 33363048)
1. The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study.
Shi W; Shen L; Zou W; Wang J; Yang J; Wang Y; Liu B; Xie L; Zhu J; Zhang Z
Front Cell Infect Microbiol; 2020; 10():562463. PubMed ID: 33363048
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study.
Yi Y; Shen L; Shi W; Xia F; Zhang H; Wang Y; Zhang J; Wang Y; Sun X; Zhang Z; Zou W; Yang W; Zhang L; Zhu J; Goel A; Ma Y; Zhang Z
Clin Cancer Res; 2021 Mar; 27(5):1329-1340. PubMed ID: 33298472
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer.
Wang H; Jia H; Gao Y; Zhang H; Fan J; Zhang L; Ren F; Yin Y; Cai Y; Zhu J; Zhu ZJ
Nat Commun; 2022 Dec; 13(1):7802. PubMed ID: 36528604
[TBL] [Abstract][Full Text] [Related]
4. Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Huang X; Chen C; Xie W; Zhou C; Tian X; Zhang Z; Wang Q; Chang H; Xiao W; Zhang R; Gao Y
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1255-1269. PubMed ID: 37433373
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.
Teng H; Wang Y; Sui X; Fan J; Li S; Lei X; Shi C; Sun W; Song M; Wang H; Dong D; Geng J; Zhang Y; Zhu X; Cai Y; Li Y; Li B; Min Q; Wang W; Zhan Q
Cancer Cell; 2023 Jan; 41(1):124-138.e6. PubMed ID: 36563680
[TBL] [Abstract][Full Text] [Related]
6. Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis.
Croner RS; Sevim M; Metodiev MV; Jo P; Ghadimi M; Schellerer V; Brunner M; Geppert C; Rau T; Stürzl M; Naschberger E; Matzel KE; Hohenberger W; Lottspeich F; Kellermann J
Int J Mol Sci; 2016 Feb; 17(2):209. PubMed ID: 26861291
[TBL] [Abstract][Full Text] [Related]
7. Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy.
Sun Y; Zhang X; Jin C; Yue K; Sheng D; Zhang T; Dou X; Liu J; Jing H; Zhang L; Yue J
J Transl Med; 2023 Mar; 21(1):221. PubMed ID: 36967379
[TBL] [Abstract][Full Text] [Related]
8. Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissue.
Babic T; Lygirou V; Rosic J; Miladinov M; Rom AD; Baira E; Stroggilos R; Pappa E; Zoidakis J; Krivokapic Z; Nikolic A
Proteomics Clin Appl; 2023 Jan; 17(1):e2100116. PubMed ID: 35997210
[TBL] [Abstract][Full Text] [Related]
9. Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.
Repetto O; De Re V; De Paoli A; Belluco C; Alessandrini L; Canzonieri V; Cannizzaro R
Oncotarget; 2017 Apr; 8(17):28328-28341. PubMed ID: 28423701
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
11. Co-Occurrence of Symptoms and Gut Microbiota Composition Before Neoadjuvant Chemotherapy and Radiation Therapy for Rectal Cancer: A Proof of Concept.
González-Mercado VJ; Lim J; Yu G; Penedo F; Pedro E; Bernabe R; Tirado-Gómez M; Aouizerat B
Biol Res Nurs; 2021 Jul; 23(3):513-523. PubMed ID: 33541122
[TBL] [Abstract][Full Text] [Related]
12. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis].
Wang XJ; Yu Q; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1183-1187. PubMed ID: 31874536
[No Abstract] [Full Text] [Related]
13. Gut microbiota differences in Island Hispanic Puerto Ricans and mainland non-Hispanic whites during chemoradiation for rectal cancer: A pilot study.
González-Mercado VJ; Lim J; Berk L; Esele M; Rodríguez CS; Colón-Otero G
Curr Probl Cancer; 2020 Aug; 44(4):100551. PubMed ID: 32057462
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Changes in Penile Microbiome Following Pediatric Circumcision.
Mishra K; Isali I; Sindhani M; Prunty M; Bell S; Mahran A; Damiani G; Ghannoum M; Retuerto M; Kutikov A; Ross J; Woo LL; Abbosh PH; Bukavina L
Eur Urol Focus; 2023 Jul; 9(4):669-680. PubMed ID: 36566099
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
17. Rectal Cancer Tissue Lipidome Differs According to Response to Neoadjuvant Therapy.
Sánchez-Vinces S; Duarte GHB; Messias MCF; Gatinoni CFA; Silva AAR; Sanches PHG; Martinez CAR; Porcari AM; Carvalho PO
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511236
[TBL] [Abstract][Full Text] [Related]
18. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
19. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
[No Abstract] [Full Text] [Related]
20. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
[Next] [New Search]